HBIO NASDAQ
Harvard Bioscience, Inc.
1W: +4.8%
1M: +1.7%
3M: +31.3%
YTD: +27.9%
1Y: +86.2%
3Y: -80.2%
5Y: -89.1%
$8.34
+0.21 (+2.58%)
Weekly Expected Move ±2.8%
$8
$8
$8
$9
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$88M
Revenue
-1.1% YoY
$-10M
Net Income
+81.9% YoY
$-2M
Free Cash Flow
-135.5% YoY
55.6%
Gross Margin
-4.3%
Op. Margin
-12.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-89.9%
ROA-13.3%
ROIC1.8%
Valuation
P/E-3.6
P/B5.1
EV/EBITDA-69.8
Leverage
Debt/Equity5.96
Current Ratio1.87
Interest Cov.-2.1x
Quality Scores
Piotroski F7/9
Altman Z-2.63
Beneish M-3.10